Cancer Breakthroughs
Morris Animal Foundation is committed to funding research to prevent, treat and, ultimately, cure cancer in dogs. Since our founding in 1948, we've funded more than 120 canine cancer studies studies, many of which have given veterinarians better tools to diagnose and treat this disease.
A few of our recent successes include:
Early Lymphoma Detection: Funding for a researcher at Colorado State University led to a simple blood test that can provide early detection of lymphoma in dogs.
Drugs to Fight Bone Cancer: Researchers at the Ohio State University studied a combination of conventional chemotherapy drugs and the drug suramin that appears to provide better treatment than conventional therapy alone and could improve long-term survival of dogs with bone cancer. Another study at the University of Illinois showed that the drug pamidronate interferes with a tumor's ability to break down bone cells and may stop the bone destruction that occurs in dogs with bone cancer. That study also resulted in the development of a new tool to objectively assess pain in these dogs.
New Chemotherapy for Epithelial Tumors: A Cornell University researcher used Foundation funding to conduct a clinical trial of a new chemotherapy combination. She learned that oral docetaxel combined with cyclosporine may successfully control oral epithelial tumors.
Search the Morris Animal Foundation Studies section to learn about additional canine cancer successes.
